gptkbp:instance_of
|
gptkb:pharmaceuticals
|
gptkbp:academic_programs
|
Ms. Susan M. Mc Carthy
|
gptkbp:acquisition
|
gptkb:Actelion
gptkb:Kymab
gptkb:Cure_Vac
gptkb:Tibotec_Pharmaceuticals
gptkb:Momenta_Pharmaceuticals
Aragon Pharmaceuticals
|
gptkbp:advertising
|
gptkb:Dr._Jennifer_Taubert
gptkb:Mr._Michael_D._Duffy
Mr. Robert A. Mc Carthy
|
gptkbp:awards
|
various industry awards
|
gptkbp:clinical_trial
|
multiple ongoing studies
|
gptkbp:conducts_research_on
|
gptkb:Dr._Mathai_Mammen
|
gptkbp:founded
|
gptkb:1959
|
gptkbp:founder
|
gptkb:Paul_Janssen
|
gptkbp:global_presence
|
over 150 countries
|
gptkbp:head_of_state
|
Dr. William Hait
Mr. John A. Mc Carthy
Ms. Linda M. Mc Carthy
|
gptkbp:headquarters
|
gptkb:Beerse,_Belgium
|
https://www.w3.org/2000/01/rdf-schema#label
|
Janssen-Cilag
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
gptkbp:number_of_employees
|
over 30,000
|
gptkbp:parent_company
|
gptkb:Johnson_&_Johnson
|
gptkbp:part_of
|
Johnson & Johnson Pharmaceutical Research & Development
|
gptkbp:partnerships
|
government agencies
non-profit organizations
various academic institutions
|
gptkbp:products
|
antibiotics
antipsychotics
oncology drugs
|
gptkbp:regulatory_compliance
|
gptkb:Ms._Jennifer_L._Mc_Carthy
|
gptkbp:research_focus
|
oncology
neuroscience
infectious diseases
immunology
|
gptkbp:supply_chain
|
Mr. David A. Mc Carthy
|
gptkbp:sustainability_initiatives
|
community health programs
diversity and inclusion efforts
environmental responsibility programs
|
gptkbp:website
|
www.janssen.com
|
gptkbp:bfsParent
|
gptkb:Janssen_Pharmaceutica
|
gptkbp:bfsLayer
|
5
|